Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jublia in mild to moderate toenail onychomycosis
NCT03280927Phase 4Completed
- Sponsor
- Dong-A ST
- Start
- Nov 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of efinaconazole in onychomycosis, sponsored by Dong-A ST. Started Nov 2017; status: completed.
02
Drugs
efinaconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT03280927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03280927.